January 01, 2025 06:01 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Indian-origin doctor among 2 killed in UAE light aircraft crash | 'We will take revenge, with interest:' Suvendu Adhikari warns Mamata Banerjee over her Sandeshkhali claims | 'Forgive and forget mistake': Manipur CM N Biren Singh apologises for ethnic clashes | Deeply malicious and utterly condemnable: Pinarayi Vijayan on BJP leader Nitesh Rane's 'Kerala is mini Pakistan' remark | Rohit Sharma to quit Test cricket after Border Gavaskar Trophy in Sydney: Report | Yemen approves death sentence for Indian nurse, MEA responds | Truth ultimately gets revealed: Mamata Banerjee in her first visit to Sandeshkhali after Lok Sabha polls | ISRO launches SpaDeX mission aimed for 'in-space docking' | 'Law is equal for all': Pawan Kayan on Allu Arjun's arrest in theatre stampede case | Highly objectionable and I was hurt that Arvind Kejriwal called Atishi temporary: Lt Governor

India gets its first covid nasal vaccine iNCOVACC manufactured by Bharat Biotech

Jan 26, 2023, at 10:11 pm

New Delhi/IBNS: Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh Thursday launched the world's first COVID-19 intranasal vaccine, iNCOVACC.

Govt approved Bharat Biotech's nasal anti-Covid vaccine: Reports

Dec 23, 2022, at 05:24 pm

New Delhi/IBNS/UNI: The central government has approved Bharat Biotech's nasal vaccine against Covid-19 amid the fresh scare of a surge in infections, media reports said.

Bharat Biotech's 1st nasal COVID vaccine gets approval for phase 2 trial

Aug 14, 2021, at 02:49 am

New Delhi/IBNS: Bharat Biotech has received phase 2 human clinical trial nod for its nasal COVID vaccine, called BBV154, the Union Government informed on Friday.

Nasal vaccine against COVID-19 prevents infection in mice: Study

Aug 23, 2020, at 03:19 am

Washignton: Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus.